EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
BioNxt Solutions Inc. (BNXTF) had EBIT Margin of -16487.96% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$0.02M |
|
$-3.88M |
|
-- |
|
$0.02M |
|
$3.27M |
|
$-3.25M |
|
$-0.69M |
|
$-3.94M |
|
$-3.94M |
|
$-3.88M |
|
$-3.88M |
|
$-3.88M |
|
$-3.88M |
|
$-3.25M |
|
$-3.18M |
|
111.41M |
|
111.41M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$0.12M |
|
$0.30M |
|
$0.30M |
|
$0.42M |
|
$5.02M |
|
$1.13M |
|
$1.13M |
|
$6.15M |
|
$-5.74M |
|
$-5.74M |
|
$-5.74M |
|
113.40M |
|
| Cash Flow Statement Financials | |
$-2.21M |
|
$0.04M |
|
$1.93M |
|
$0.27M |
|
$0.02M |
|
$-0.24M |
|
$0.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.02 |
|
-- |
|
-- |
|
-0.25 |
|
-0.54 |
|
100.00% |
|
-16487.96% |
|
|
EBIT Margin |
-16487.96% |
-16147.92% |
|
-20015.92% |
|
-19683.18% |
|
$-2.17M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
0.45 |
|
819.66 |
|
67.56% |
|
67.56% |
|
-932.90% |
|
84.20% |
|
$-0.05 |
|
$-0.02 |
|
$-0.02 |
|